RSS

RedHill Biopharma

Speciality biopharmaceutical company, RedHill Biopharma, has received notices of allowance from the US Patent and Trademark Office (USPTO) for two new patents covering BEKINDA (RHB-102). more

News

RedHill Biopharma has signed an exclusive licensing agreement for the commercialisation of Entera Health’s gastrointestinal speciality products, Donnatal and EnteraGam. more

News

RedHill Biopharma has announced that its treatment for cholangiocarcinoma, Yeliva (ABC294640), has been granted orphan drug designation by the FDA. more

News

RedHill Biopharma has announced dosing of the first patient in the open-label extension study to the Phase III study with RHB-104 for the treatment of Crohn’s disease. more

News